Alloy Therapeutics vs Evotec
Alloy Therapeutics vs Evotec, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Alloy Therapeutics is on 51/100 and Evotec on 57/100.
Where each one leads
Alloy Therapeutics
- funding raised: $157M against $26.9M
Evotec
- our overall score: 57/100 against 51/100
- agent readiness: 45/100 against 39/100
- domain rating: 69/100 against 47/100
At a glance
| Measure | Alloy Therapeutics | Evotec |
|---|---|---|
| What it is | A biotechnology ecosystem company powering the future of drug discovery and development through AI-driven platforms and integrated services. | Life science company pioneering drug discovery with AI and advanced technologies. |
| Category | Biotechnology, Artificial Intelligence, Drug Discovery, Drug Development | Drug Discovery, Biotech, AI-Driven Drug Discovery, Life Sciences |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Platform |
| Founded | 2017 | 1993 |
| Headquarters | Boston, USA | Hamburg, Germany |
| Status | Active | Active |
Size, funding and growth
| Measure | Alloy Therapeutics | Evotec |
|---|---|---|
| Employees | Not published | 4,837 |
| Total funding | $157M | $26.9M |
| Latest round | Series E | Series A |
| Valuation | $1.0B | Not published |
| LinkedIn followers | Not published | 121,725 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Alloy Therapeutics | Evotec |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 51/100 | 57/100 |
| Traction | 40/100 | 57/100 |
| Team | 30/100 | 70/100 |
| Search visibility | 15/100 | 34/100 |
| Quality | 68/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (39/100) | D (45/100) |
| Domain ratingLink authority, 0-100 | 47/100 | 69/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Alloy Therapeutics | Evotec |
|---|---|---|
| Hosting | Not detected | Self Managed |
| CDN | Cloudflare | Not detected |
| CMS | WordPress | Not detected |
| Frameworks | Jquery | Not detected |
| Analytics | Google Tag Manager | Google Tag Manager, Matomo |
| Support stack | HubSpot | HubSpot |
Alloy Therapeutics vs Evotec: common questions
Which is better, Alloy Therapeutics or Evotec?
On our 0-100 score Evotec rates higher (57/100 against 51/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.
How do Alloy Therapeutics and Evotec compare on the numbers?
Alloy Therapeutics leads on funding raised ($157M against $26.9M). Evotec leads on our overall score (57/100 against 51/100), agent readiness (45/100 against 39/100), domain rating (69/100 against 47/100).
Read the full Alloy Therapeutics review and pricing or the Evotec review and pricing. You can also browse other Alloy Therapeutics alternatives we track.